SYSTEMATIC REVIEW
Published on 16 Jul 2026
Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review
doi 10.3389/fimmu.2026.1870010
- 1,082 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- ADCs and Beyond: The Next Frontier in Biologic Therapies for Cancer
ADCs and Beyond: The Next Frontier in Biologic Therapies for Cancer
3,196
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Published on 14 May 2026
Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges
doi 10.3389/fimmu.2026.1774353
- 2,613 views
ORIGINAL RESEARCH
Published on 29 Apr 2026
Disitamab vedotin (RC48) combined with PD-1 inhibitors in locally advanced or metastatic urothelial carcinoma: clinical outcomes and prognostic factors from a multicenter real-world study
doi 10.3389/fimmu.2026.1815591
- 1,700 views
- 1 citation
REVIEW
Published on 27 Apr 2026
Ocular toxicity associated with antibody-drug conjugates in cancer therapy: a comprehensive review
doi 10.3389/fimmu.2026.1698458
- 3,879 views
- 3 citations
CASE REPORT
Published on 17 Apr 2026
Case Report: Complete metabolic responses to trastuzumab–deruxtecan in HER2-altered solid tumors: two illustrative cases
doi 10.3389/fimmu.2026.1752694
- 1,487 views
- 1 citation
SYSTEMATIC REVIEW
Published on 24 Mar 2026
Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis of emerging clinical evidence
doi 10.3389/fimmu.2026.1728521
- 1,985 views
SYSTEMATIC REVIEW
Published on 12 Jan 2026
Sacituzumab govitecan as a therapeutic breakthrough in the treatment of triple-negative breast cancer: a systematic review of clinical trials
doi 10.3389/fimmu.2025.1679648
- 3,906 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Jan 2026
Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study
doi 10.3389/fimmu.2025.1699538
- 2,608 views
- 4 citations
SYSTEMATIC REVIEW
Published on 06 Nov 2025
The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data
doi 10.3389/fimmu.2025.1683594
- 4,749 views
- 4 citations
CASE REPORT
Accepted on 25 Jul 2026
Trastuzumab-Deruxtecan as 11th line therapy in a metastasized ovarian clear cell carcinoma patient expressing HER2 1+
- 588 views
SYSTEMATIC REVIEW
Accepted on 06 Aug 2026
Antibody–Drug Conjugate Development in Lymphoma: A Systematic Clinical Trial Landscape Analysis
- 112 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.4 impact factor
- 6.6 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: